Follow the Pharmala Biotech Holdings Inc. share price and the full directors' dealings record of the company, a listed equity based in Canada. Shares trade on the CA market, under the authority of SEDI. The latest transaction was filed on 29 July 2026 (56 - Grant of rights). Among the most active insiders: Macdonald, Fraser. All data is accessible without an account.
14
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
25Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
175,000 shares@ CA$0.1050.0% of flowOptionsTSXSEDI:4734887
14 of 14 declarations
Acerca de Pharmala Biotech Holdings Inc.
Pharmala Biotech Holdings Inc. es una empresa centrada en el desarrollo de productos farmacéuticos basados en cannabis. Cotiza en la Bolsa de Valores de Toronto.